IP Library › Granted Patent US 12,440,169
Granted Patent B2
US 12,440,169 · App. 16/218,694 · Granted Oct 14, 2025

Determining prospective risk of heart failure hospitalization

Inventors: Vinod Sharma (Maple Grove, MN); Eduardo N. Warman (Maple Grove, MN); Karen J. Kleckner (Blaine, MN)
Assignee: Medtronic, Inc.
A61B5/7275A61B5/0031A61B5/0205A61B5/14503A61B5/14532A61B5/14535A61B5/14546A61B5/339A61B5/4836A61B5/686A61B5/7278A61B5/7435A61B5/7475G16H20/00G16H20/40G16H50/20G16H50/30A61B5/0036A61B5/0537A61B5/1118A61B5/361A61B5/363A61B5/6869A61B2505/07
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,440,169
App. No.
16/218,694
Granted
Oct 14, 2025
Kind
B2
Abstract

A method of operation of a medical device system for determining prospective heart failure hospitalization risk. The method includes measuring one or more data observations via one or more electrodes of an implanted medical device disposed in a patient's body. The data observations are stored into memory of the implantable medical device of a patient. The data observations are transmitted to an external device. The processor of the external device parses the data observations into one or more evaluation periods. Using the number of observations in one or more evaluation periods, a look up table, stored into memory of the external device, is accessed. The look up table associates prospective heart failure hospitalization risk with the data observations noted in the evaluation period. One or more embodiments involve a weighted prospective heart failure hospitalization risk for the set of evaluation periods. The prospective heart failure hospitalization is then displayed on the graphical user interface.

Claims (43)

1. A method of operation of a medical system for determining prospective heart failure hospitalization (HFH) risk, the method comprising:

providing one or more implantable sensors to detect one or more patient metrics;

detecting, using the one or more implantable sensors, the one or more patient metrics;

determining, using a computing device in communication with the implantable sensors, a number of an individual heart failure patient's detected data observations during an individual evaluation period, the detected data observations comprising a number of times each of the one or more patient metrics detected by the one or more implantable sensors exceeds a representative value, the one or more detected patient metrics comprising one or more of an atrial tachycardia/atrial fibrillation (AT/AF) daily burden, a time in AT/AF, a night heart rate (NHR), an intrathoracic impedance, a thoracic impedance, heart rate variability, ventricular intrinsic pacing rate, atrial intrinsic pacing rate, heart rate, respiration rates, tidal volume, an atrial defibrillation duration, a ventricular contraction rate during atrial fibrillation, a cardiac resynchronization therapy percentage, a mean ventricular rate during AT/AF, and a V rate;

employing, using the computing device, a lookup table to determine prospective heart failure hospitalization risk based upon the determined number of the detected data observations during the said individual evaluation period;

displaying, on a graphical user interface in communication with the computing device, the prospective risk of HFH;

using the prospective risk to suggest a therapy;

displaying on the graphical user interface the therapy or transmitting the therapy;

using the prospective risk to modify therapy delivered by an implantable medical device; and

delivering the modified therapy to the patient using the implantable medical device;

wherein the lookup table comprises a set of data observations categories and for each said category a stored ratio;

wherein each said data observations category defines a total number of group data evaluation periods each having a defined same number of data observations from a population of patients therein; and

wherein the stored ratio for each said data observations category comprises a ratio of heart failure hospitalizations associated with the said data observations category to the total number of group evaluation periods within the said data observations category.

2. A method of operation of a medical system for determining prospective heart failure hospitalization (HFH) risk, the method comprising:

providing one or more implantable sensors to detect one or more patient metrics;

detecting, using the implantable sensors, the one or more patient metrics;

determining, using a computing device in communication with the implantable sensors, a number of an individual heart failure patient's detected data observations during an individual evaluation period, the number of detected data observations being determined without regard as to a type of detected data observations, the detected data observations comprising a number of times each of the one or more patient metrics detected by the one or more implantable sensors exceeds a representative value, the one or more detected patient metrics comprising one or more of an atrial tachycardia/atrial fibrillation (AT/AF) daily burden, a time in AT/AF, an NHR, an intrathoracic impedance, a thoracic impedance, heart rate variability, ventricular intrinsic pacing rate, atrial intrinsic pacing rate, heart rate, respiration rates, tidal volume, an atrial defibrillation duration, a ventricular contraction rate during atrial fibrillation, a cardiac resynchronization therapy percentage, a mean ventricular rate during AT/AF, and a V rate;

employing, using the computing device, a lookup table to determine prospective heart failure hospitalization risk based upon the determined number of detected data observations during the said individual evaluation period;

displaying on a graphical user interface the prospective risk of HFH;

using the prospective risk to suggest a therapy;

displaying, on the graphical user interface in communication with the computing device, the therapy or transmitting the therapy;

using the prospective risk to modify therapy delivered by an implantable medical device; and

delivering the modified therapy to the patient using the implantable medical device;

wherein the lookup table comprises a set of data observations categories and for each said category a stored ratio; and

wherein each said data observations category defines a total number of group data evaluation periods each having a defined same number of data observations from a population of patients therein.

3. The method of claim 2 wherein the stored ratio for each said data observations category comprises a ratio of heart failure hospitalizations associated with the said data observations category to the total number of group evaluation periods within the said data observation category.

4. A medical system for determining prospective heart failure hospitalization risk (HFH), the system comprising:

an implantable medical device;

one or more implantable sensors to detect one or more patient metrics;

a graphical user interface to display a prospective risk of HFH;

a telemetry module; and

a computing device in communication with each of the graphical user interface, the telemetry module, the implantable sensors, and the implantable medical device, the computing device configured to:

detect, using the implantable sensors, the one or more patient metrics;

determine a number of an individual heart failure patient's detected data observations during an individual evaluation period, the detected data observations comprising a number of times each of the one or more patient metrics detected by the one or more implantable sensors exceeds a representative value, the one or more detected patient metrics comprising one or more of an atrial tachycardia/atrial fibrillation (AT/AF) daily burden, a time in AT/AF, an NHR, an intrathoracic impedance, a thoracic impedance, heart rate variability, ventricular intrinsic pacing rate, atrial intrinsic pacing rate, heart rate, respiration rates, tidal volume, an atrial defibrillation duration, a ventricular contraction rate during atrial fibrillation, a cardiac resynchronization therapy percentage, a mean ventricular rate during AT/AF, and a V rate;

employ a lookup table to determine prospective heart failure hospitalization risk based upon the determined number of detected data observations during the said individual evaluation period;

display on the graphical user interface the prospective risk of HFH;

use the prospective risk to suggest a therapy;

display on the graphical user interface the therapy or transmit the therapy via the telemetry module;

modify, using the prospective risk, therapy delivered by the implantable medical device; and

deliver, using the implantable medical device, the modified therapy to the patient;

wherein the lookup table comprises a set of data observations categories and for each said category a stored ratio;

wherein each said data observations category defines a total number of group data evaluation periods each having a defined same number of data observations from a population of patients therein; and

wherein the stored ratio for each said data observations category comprises a ratio of heart failure hospitalizations associated with the said data observations category to the total number of group evaluation periods within the said data observations category.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2025
From: SHARMA, VINOD; WARMAN, EDUARDO N.; KLECKNER, KAREN J.
To: MEDTRONIC, INC.
Reel/Frame 071841/0309 →
Continuity (4)
Division 14798225 · Jul 13, 2015
Provisional Application 62037895 · Aug 15, 2014
Provisional Application 62024285 · Jul 14, 2014
Related Publication 20190110756A1 · Apr 18, 2019
References Cited (61)
US 4374382A · Markowitz · 1983 [cited by applicant]
US 5117824A · Keimel et al. · 1992 [cited by applicant]
US 5545186A · Olson et al. · 1996 [cited by applicant]
US 5755736A · Gillberg et al. · 1998 [cited by applicant]
US 7013176B2 · Ding et al. · 2006 [cited by applicant]
US 7127290B2 · Girouard et al. · 2006 [cited by applicant]
US 7682316B2 · Anderson et al. · 2010 [cited by applicant]
US 7986994B2 · Stadler et al. · 2011 [cited by applicant]
US 8036749B2 · Ziegler et al. · 2011 [cited by applicant]
US 8052611B2 · Wariar et al. · 2011 [cited by applicant]
US 8255046B2 · Sarkar et al. · 2012 [cited by applicant]
US 8346360B2 · Libbus et al. · 2013 [cited by applicant]
US 8435186B2 · Hettrick et al. · 2013 [cited by applicant]
US 8478400B2 · Hettrick et al. · 2013 [cited by applicant]
US 8639328B2 · Hettrick et al. · 2014 [cited by applicant]
US 8688469B2 · Ziegler et al. · 2014 [cited by applicant]
US 8744565B2 · Zielinski et al. · 2014 [cited by applicant]
US 8768718B2 · Cazares et al. · 2014 [cited by applicant]
US 8777850B2 · Cho et al. · 2014 [cited by applicant]
US 8831721B2 · Hettrick et al. · 2014 [cited by applicant]
US 8914101B2 · Hettrick et al. · 2014 [cited by applicant]
US 8938292B2 · Hettrick et al. · 2015 [cited by applicant]
US 8948868B2 · Vitense et al. · 2015 [cited by applicant]
US 10092186B2 · Hatlestad et al. · 2018 [cited by applicant]
US 20070288059A1 · Davenport et al. · 2007 [cited by applicant]
US 20080103530A1 · Vitense et al. · 2008 [cited by applicant]
US 20080119903A1 · Arcot-Krishnamurthy et al. · 2008 [cited by applicant]
US 20080228090A1 · Wariar et al. · 2008 [cited by applicant]
US 20090125328A1 · Nevins · 2009 [cited by applicant]
US 20090270933A1 · Hettrick et al. · 2009 [cited by applicant]
US 20090275855A1 · Zielinski et al. · 2009 [cited by applicant]
US 20100030087A1 · Hettrick et al. · 2010 [cited by applicant]
US 20100030292A1 · Sarkar et al. · 2010 [cited by applicant]
US 20100030293A1 · Sarkar et al. · 2010 [cited by applicant]
US 20100113888A1 · Cho et al. · 2010 [cited by applicant]
US 20100113962A1 · Hettrick et al. · 2010 [cited by applicant]
US 20100204550A1 · Heneghan et al. · 2010 [cited by applicant]
US 20120109243A1 · Hettrick et al. · 2012 [cited by applicant]
US 20120109245A1 · Hettrick et al. · 2012 [cited by applicant]
US 20120109675A1 · Ziegler et al. · 2012 [cited by applicant]
US 20120253207A1 · Sarkar et al. · 2012 [cited by applicant]
US 20120303085A1 · Vitense et al. · 2012 [cited by applicant]
US 20130030319A1 · Hettrick et al. · 2013 [cited by applicant]
US 20130197599A1 · Sambelashvili et al. · 2013 [cited by applicant]
US 20140288455A1 · Zielinski et al. · 2014 [cited by applicant]
US 20150088216A1 · Gordon et al. · 2015 [cited by applicant]
US 20150126883A1 · An et al. · 2015 [cited by applicant]
US 20150230722A1 · Sarkar et al. · 2015 [cited by applicant]
CN 103796714B · 2014 [cited by applicant]
CN 106659403A · 2017 [cited by applicant]
EP 2008581A2 · 2008 [cited by applicant]
EP 2187807B1 · 2012 [cited by applicant]
WO 2009036329A1 · 2009 [cited by applicant]
WO 2011053434A1 · 2011 [cited by applicant]
WO 2011126823A1 · 2011 [cited by applicant]
WO 2012135775A1 · 2012 [cited by applicant]
M. Pechenizkiy, “Heart Failure Hospitalization Prediction in Remote Patient Management Systems”, et al., 2010 IEEE, pp. 44-49. [cited by applicant]
Martin R. Cowie et al., “Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an… [cited by applicant]
(PCT/US2015/040383) PCT Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, mailed Oct. 14, 2015, 11 pages. [cited by applicant]
(PCT/US2016/065768) PCT Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, mailed Mar. 16, 2017, 10 pages. [cited by applicant]
Sarkar et al, Method and Apparatus for Monitoring Tissue Fluid Content for Use in an Implantable Cardiac Device, U.S. Appl. No. 13/391,376, filed Mar. 29, 2011, 87 pages. [cited by applicant]